Dr. Amelia Seifalian | Urogynaecology | Young Scientist Award
Student, Imperial College London, United Kingdom
Dr. Amelia Susanna Seifalian is a highly accomplished Obstetrics and Gynaecology Specialty Trainee (ST3) at Watford General Hospital, currently pursuing her research at Imperial College London. With a strong academic background, Dr. Seifalian is involved in groundbreaking research on the development of novel pelvic membranes using graphene-based nanocomposite materials and stem cell technology. Alongside her clinical training, she is a rising star in medical innovation, contributing significantly to scientific publications that focus on the application of advanced materials in women’s health. 🩺🔬
Publication Profile
Education
Dr. Seifalian holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from University College London (2020), where she also completed an Integrated Bachelor of Science (iBSc) in Medical Sciences with Global Health (2017). She is currently pursuing a Ph.D. in collaboration with Imperial College London, under the supervision of leading professors in urogynaecology and HPB surgery. 🎓📚
Experience
Dr. Seifalian has diverse experience in obstetrics and gynaecology, having worked as a Specialty Trainee (ST1-3) at Watford General Hospital since 2020. She has gained comprehensive exposure in various medical disciplines, including general surgery, gastroenterology, and emergency medicine, honing her skills in high-pressure healthcare settings. 🏥💼
Awards and Honors
Dr. Seifalian’s contributions to medical science and practice have been widely recognized. She has authored multiple peer-reviewed publications, contributing innovative research on the use of graphene in medical treatments. 🎖️🏆
Research Focus
Her current research focuses on developing cutting-edge graphene-based nanomaterials for use in pelvic implants to treat pelvic organ prolapse. This groundbreaking work combines nanotechnology and stem cell therapy to improve patient outcomes in women’s health. 🧬💡
Conclusion
Dr. Seifalian’s dedication to advancing both her clinical practice and research demonstrates her commitment to improving healthcare outcomes for women. Her work in developing innovative materials for pelvic health has the potential to revolutionize treatments for pelvic organ prolapse. 👩🔬🌍
Publications
A Novel Graphene-Based Nanomaterial for the Development of a Pelvic Implant to Treat Pelvic Organ Prolapse. J Funct Biomater, 15:351. [Cited by: 5.0]
Graphene-based nanocomposite materials to provide a surgical solution for the condition of pelvic organ prolapse. Med Hypotheses, 189:111398. [Cited by: 1.5]
The use of animal models in preclinical investigations for the development of a surgical mesh for pelvic organ prolapse. Int Urogynecol J., 35:741-758. [Cited by: 2.9]
Polypropylene Pelvic Mesh: What went wrong and what will be of the future? Biomedicines, 11:741. [Cited by: 4.8]
Graphene-Based Materials for Inhibition of Wound Infection and Accelerating Wound Healing. Biomed Pharmacother, 158:114184. [Cited by: 6.5]
Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally? Int J Mol Sci, 23:16201. [Cited by: 6.2]
An Overview on the Recent Advances in the Treatment of Infected Wounds: Antibacterial Wound Dressings. Macromol Biosci, 22:e2200014. [Cited by: 5]